Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Staar Surgical Q3 2026 Results: Net Income $5.58M, Down 37.2% YoY

STAAR Surgical reported net income of $18.8 million for the first nine months of 2026, a significant recovery from a net loss of $62.1 million in the prior year period. Net sales grew to $270.5 million from $181.6 million year-over-year, driven by improved operating income and reduced restructuring and impairment charges.

Watch the Staar Surgical Co earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue83.494.7
Gross profit59.177.9
Profit before tax7.018.8
Net income5.68.9
EPS (diluted, $ a share)$0.11$0.18

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-37.2%
Revenue, year on year-12.0%
Gross margin70.9%
Operating margin6.5%
Source

10-Q filed with the SEC, NASDAQ: STAA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Staar Surgical Co: key numbers

Share price
$26.01Close, Nov 16
Market cap
$1.31B
Shares outstanding
50.2MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Ophthalmic GoodsSIC 3851

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Staar Surgical Co

All →
4:03 PM ET 8-K
Financial Results

Staar Surgical Financial Results

STAAR Surgical reported third quarter 2026 net sales of $83.4 million and net income of $5.6 million. The company achieved record year-to-date revenue of $270.5 million and authorized a new $50 million share repurchase program during the period.

Term
Q3 2026
12:26 PM ET 8-K/A
Executive Compensation

Staar Surgical Executive Compensation

STAAR Surgical Company appointed former CEO David Bailey as Chief Commercial Officer, effective September 8, 2026. His compensation package includes an annual base salary of approximately $575,000, a target cash bonus of 60% of base salary, and initial equity grants totaling $2.25 million in value (comprised of an $850,000 sign-on grant and a $1.4 million annual long-term incentive award).

Counterparty
David Bailey

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.